Greece bans Novartis influenza vaccines

Influenza vaccines produced by Swiss pharmaceuticals manufacturer Novartis are not to be sold in Greece until further notice, it was announced on Thursday.

The ban, which follows a similar move in Italy, applied to the drugs Agrippal, Fluad and Influpozzi.

According to reports, the Italian Pharmaceutical Agency ordered the ban following indications of possible side effects and ordered further tests on the drugs.

Subscribe to our Newsletters

Enter your information below to receive our weekly newsletters with the latest insights, opinion pieces and current events straight to your inbox.

By signing up you are agreeing to our Terms of Service and Privacy Policy.